23 Nov 2022
In memoriam: Nathalie Josso (1934 - 2022)
Nathalie Josso, MD, PhD, was born in Paris in 1934. She obtained her MD degree from the University of Paris and did her internship in Paediatrics at Necker-Enfant Malades Hospital. Passionate about research, she was a disciple of Alfred Jost at Collège de France, with whom she learned about the existence of the “Müllerian inhibitor”. Nathalie combined clinical work as a consultant in Paediatric Endocrinology and her passion as a researcher at INSERM. She created the Unité de Recherches sur l’Endocrinologie du Développement at the Ecole Normale Supérieure, where she led a successful team that resolved the glycoprotein nature of the Müllerian inhibitor ―that she named Anti-Müllerian hormone (AMH)―, and then subsequently cloned its gene and the gene of its specific receptor AMHR2. An ESPE member, Nathalie received the Andrea Prader Prize in 1992 as the major contributor to the knowledge on AMH. She never abandoned her passion for AMH, and has been an active author until recently. Nathalie was fond of Paris, arts and boating; she loved sharing her time with her family and friends. Nathalie left us on November 20th 2022, surrounded by her family, serene, after a happy and full life.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024